 SAN DIEGO, Calif., Nov. 19, 2020 GLOBE NEWSWIRE -- Maravai LifeSciences Holdings, Inc. Maravai NASDAQ: MRVI, a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of its upsized initial public offering of 60,000,000 shares of Class A common stock at a public offering price of 27.00 per share, before underwriting discounts and commissions, for gross proceeds of 1,620,000,000. All shares of Class A common stock are being offered by Maravai. The shares are expected to begin trading on the Nasdaq Global Select Market on November 20, 2020, under the symbol MRVI. The offering is expected to close on November 24, 2020, subject to the satisfaction of customary closing conditions. Additionally, Maravai has granted the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions. 